PROCEPT BioRobotics Corporation

PRCT

CIK 0001588978 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$76M
↑+11.9% +$8Mvs FY2024 (Q4)
Gross Profit
$46M
↑+6.0% +$3Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
63/100
  • Profitability
    0ROIC -18.8% (10% = solid, 20%+ = moat)
  • Liquidity
    100Current Ratio 6.85 (above 1.5 = solid)
  • Leverage
    93D/E 0.14 (under 0.5 = conservative)
  • Efficiency
    30Asset Turnover 0.59x (1.0+ = capital-efficient)
  • Growth
    56Revenue YoY +11.9% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin -27.8% · trend +18.4pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$9M
investment in PP&E
Stock-based comp (TTM)
$48M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$508M
everything owned
Total liabilities
$142M
everything owed
Stockholders' equity
$366M
shareholder claim
Net debt
$-235M
Net cash position ($235M)

Recent performance · 24 quarters

Revenue↑+11.9% +$8M
$76M
Net Income↓-2.1% -$437K
$-21M
Free Cash Flow↓-57.6% -$676K
$-2M
Operating Margin↑+10.6pts
-27.8%

Drill down